596 results on '"Staubach, Petra"'
Search Results
2. Profound Sexual Dysfunction Among Patients with Hidradenitis Suppurativa: A Cross-sectional Study
3. Versorgung und Krankheitskosten der Urtikaria bei Kindern in Deutschland: Arzneimittel, ärztliche und stationäre Leistungen
4. Management dermatologischer Symptome
5. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus
6. Non–Skin Related Symptoms Are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results From the Chronic Urticaria Registry
7. Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
8. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
9. Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics
10. Multidisziplinarität als Schlüssel zum Erfolg: Zusammenarbeit zwischen Dermatologie und Rheumatologie zur Optimierung der Patientenversorgung
11. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results
12. Gene Mutations Linked to Hereditary Angioedema in Solitary Angioedema Patients With Normal C1 Inhibitor
13. Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
14. Real‐world effectiveness and safety of the LAight‐therapy in patients with hidradenitis suppurativa
15. A narrative review of fixed combination calcipotriol/betamethasone aerosol foam (Enstilar®) in the management of psoriasis with scalp involvement
16. The socio‐economic burden of H1‐antihistamine‐refractory chronic spontaneous urticaria in Germany
17. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries
18. Belastung durch gestörten Schlaf und dessen Verbesserung durch topische Behandlung bei Psoriasis und atopischer Dermatitis
19. Non-Skin-Related Symptoms are Common in Chronic Spontaneous Urticaria and Linked to Active and Uncontrolled Disease: Results from CURE
20. Urticaria in Pediatrics and During Pregnancy and Lactation: Highlights on Epidemiology, Diagnosis, and Management
21. Die Notwendigkeit von Galenikunterricht in der studentischen Ausbildung: ein Erfahrungsbericht.
22. Real‐World‐Effektivität und Sicherheit der LAight‐Therapie bei Patienten mit Hidradenitis suppurativa.
23. Fenebrutinib in H.sub.1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
24. Maladaptive stress coping: An additional psychological factor in the process of chronification of pain or pruritus
25. Modelling of patient journey in chronic spontaneous urticaria: Increasing awareness and education by shorten patients' disease journey in Germany
26. Remibrutinib monotherapy reduced rescue medication in chronic spontaneous urticaria patients: Findings from a Phase 2b extension study
27. Hidradenitis Suppurativa Is Associated with Severe Sexual Impairment
28. Chronic Urticaria and Recurrent Angioedema: Clues to the Mimics
29. UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities.
30. Kinderdermatologie – Was ist beim Rezeptieren zu beachten?
31. Expert consensus on practical aspects in the treatment of chronic urticaria
32. Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.
33. Burden of impaired sleep and its improvement through topical treatment in psoriasis and atopic dermatitis.
34. Afamelanotide in protoporphyria and other skin diseases: a review.
35. Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control
36. Garadacimab for the prevention of hereditary angioedema attacks: a plain language summary of the VANGUARD study
37. A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effectiveness
38. Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial
39. Drivers of disease severity and burden of hidradenitis suppurativa: a cross‐sectional analysis on 553 German patients
40. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
41. Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi survey
42. EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MODERATE-TO-SEVERE GENITAL PSORIASIS: RESULTS FROM DISCREET, A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
43. Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern
44. Arzneitherapie des chronischen Pruritus – Licht am Ende des langen Tunnels?
45. Fertigarzneimittel Glukokortikosteroidgel außer Handel – Ersatz durch Magistralrezepturen
46. ARIA guideline 2019: treatment of allergic rhinitis in the German health system
47. Drivers of disease severity and burden of hidradenitis suppurativa: a cross‐sectional analysis on 553 German patients.
48. Efficacy and safety of on‐demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trial.
49. Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment
50. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.